CLINUVEL

Serial Number 79219190
Registration 5563153
708

Registration Progress

Application Filed
May 11, 2017
Under Examination
Approved for Publication
Jul 3, 2018
Published for Opposition
Jul 3, 2018
Registered
Sep 18, 2018

Trademark Image

CLINUVEL

Basic Information

Serial Number
79219190
Registration Number
5563153
Filing Date
May 11, 2017
Registration Date
September 18, 2018
Published for Opposition
July 3, 2018
Drawing Code
4

Status Summary

Current Status
Active
Status Code
708
Status Date
Jul 3, 2025
Registration
Registered
Classes
005

Rights Holder

Clinuvel Pharmaceuticals Limited

99
Address
Level 6 / 15 Queen Street
Melbourne VIC 3000
AU

Ownership History

Clinuvel Pharmaceuticals Limited

Original Applicant
99
AU

Clinuvel Pharmaceuticals Limited

Owner at Publication
99
AU

Clinuvel Pharmaceuticals Limited

Original Registrant
99
Melbourne VIC AU

Legal Representation

Attorney
Keith A. Weltsch

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

33 events
Date Code Type Description Documents
Jul 3, 2025 C75P O REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK. Loading...
Jul 3, 2025 NA75 E NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED Loading...
Jun 30, 2025 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Mar 15, 2025 ES75 I TEAS SECTION 71 & 15 RECEIVED Loading...
Sep 18, 2023 REM3 E COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED Loading...
Jan 17, 2019 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Dec 29, 2018 FIMP P FINAL DISPOSITION PROCESSED Loading...
Dec 29, 2018 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Dec 18, 2018 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Sep 18, 2018 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jul 3, 2018 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 3, 2018 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 13, 2018 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 25, 2018 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
May 25, 2018 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
May 25, 2018 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
May 25, 2018 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 25, 2018 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
May 21, 2018 GNFR O FINAL REFUSAL E-MAILED Loading...
May 21, 2018 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
May 21, 2018 CNFR R FINAL REFUSAL WRITTEN Loading...
Apr 30, 2018 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Apr 27, 2018 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 27, 2018 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Dec 1, 2017 RFNT P REFUSAL PROCESSED BY IB Loading...
Nov 9, 2017 RFRR P REFUSAL PROCESSED BY MPU Loading...
Nov 9, 2017 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Nov 2, 2017 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Nov 1, 2017 CNRT R NON-FINAL ACTION WRITTEN Loading...
Oct 31, 2017 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Oct 26, 2017 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 26, 2017 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 19, 2017 SDRC M SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB Loading...

Detailed Classifications

Class 005
Pharmaceuticals and pharmaceutical preparations for the treatment of skin disorders; pharmaceuticals and pharmaceutical preparations for the treatment of skin disorders, based on analogues of melanocyte stimulating hormone, in particular afamelanotide pharmaceuticals and pharmaceutical preparations for the treatment of damaged skin and tissue; pharmaceuticals and pharmaceutical preparations for the treatment of sunburn; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for skin care; medicated skin care preparations; medicated sun tanning preparations; medicated sun tanning preparations for pharmaceutical purposes, based on analogues of melanocyte stimulating hormone, in particular afamelanotide; diagnostic preparations for medical purposes; [ chemical and biological preparations, substances, reagents and compounds, namely, pharmaceutical preparations for use in dermatology, for skin care, for the treatment of skin disorders, for the protection of the dermis and epidermis, all used in the manufacture, delivery and storage of pharmaceuticals, drugs and diagnostic preparations ] ; vaccines; chemical reagents comprised of polyvalent compounds and synthetic molecules, for medical and veterinary purposes

Classification

International Classes
005